|
End-of-day quote
Shenzhen S.E.
2026-09-04
|
5-day change | 1st Jan Change | ||
| 5.880 CNY | -1.34% |
|
-6.37% | -20.22% |
| 08-25 | Beijing SL Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 06-01 | Beijing SL Pharmaceutical Co., Ltd. Approves Cash Dividend for 2025 | CI |
| Market Cap | 6.04B 900M 774M 728M 665M 1.24B 84.95B 1.25B 8.61B 3.34B 43.59B 3.38B 3.31B 140B | P/E 2024 |
-107x | P/E 2025 | -21.7x |
|---|---|---|---|---|---|
| Enterprise Value | 4.9B 730M 628M 591M 540M 1.01B 68.9B 1.01B 6.98B 2.71B 35.35B 2.74B 2.68B 114B | EV / Sales 2024 |
8.62x | EV / Sales 2025 | 10.3x |
| Free-Float |
59.66% | Yield 2024 |
0.27% | Yield 2025 | 0.14% |
| 1 day | -1.34% | ||
| 1 week | -6.37% | ||
| Current month | -1.67% | ||
| 1 month | +3.34% | ||
| 3 months | +5.00% | ||
| 6 months | -6.07% | ||
| Current year | -20.22% |
| 1 week | 5.84 |  | 6.19 |
| 1 month | 5.82 | | 7.08 |
| Current year | 4.81 | | 9.4 |
| 1 year | 4.81 | | 9.4 |
| 3 years | 4.81 | | 16.09 |
| 5 years | 4.81 | | 16.09 |
| 10 years | 4.81 | | 33.03 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ming Bo Xu
CEO | Chief Executive Officer | 62 | 2006-04-10 |
Li Ji
DFI | Director of Finance/CFO | 45 | 2023-04-23 |
Shu Jie Liang
SEC | Corporate Secretary | 60 | 2006-04-10 |
| Director | Title | Age | Since |
|---|---|---|---|
Ming Bo Xu
CHM | Chairman | 62 | 2006-04-10 |
Shu Jie Liang
BRD | Director/Board Member | 60 | 2009-04-23 |
Yu Lin Chen
BRD | Director/Board Member | 81 | 2006-04-10 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 11/5/25 | Buy | Director | 100 | 0.0000% | ||
| 10/29/25 | Sell | Director | 35,100 | 0.0041% | ||
| 10/28/25 | Sell | Director | 340,000 | 0.0399% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.34% | -6.37% | -23.24% | -34.30% | 900M | |
| -0.88% | -2.15% | +58.05% | +105.26% | 1,024B | |
| -1.15% | +2.68% | +54.25% | +74.19% | 663B | |
| -1.44% | +0.38% | +20.65% | +76.13% | 453B | |
| +0.14% | -0.47% | +30.20% | +41.44% | 352B | |
| -1.33% | +4.72% | +24.62% | +48.58% | 304B | |
| -1.15% | +0.30% | -0.69% | +13.20% | 252B | |
| -1.55% | +1.11% | +54.15% | +75.59% | 236B | |
| -0.88% | +1.15% | -14.60% | -54.96% | 206B | |
| -0.15% | +3.65% | +31.24% | +103.39% | 187B | |
| Average | -0.97% | +0.82% | +23.46% | +44.85% | 367.93B | |
| Weighted average by Cap. | -0.96% | +0.55% | +37.62% | +67.99% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 660M 98.37M 84.65M 79.64M 72.75M 136M 9.29B 136M 941M 365M 4.77B 369M 361M 15.35B | 624M 92.89M 79.93M 75.21M 68.7M 129M 8.77B 129M 889M 345M 4.5B 349M 341M 14.5B |
| Net income | -74.07M -11.03M -9.49M -8.93M -8.16M -15.26M -1.04B -15.3M -106M -40.96M -534M -41.43M -40.52M -1.72B | -347M -51.72M -44.5M -41.87M -38.25M -71.55M -4.88B -71.75M -495M -192M -2.51B -194M -190M -8.07B |
| Net Debt | -1.98B -295M -254M -239M -218M -409M -27.88B -410M -2.82B -1.1B -14.3B -1.11B -1.08B -46.08B | -1.14B -170M -146M -138M -126M -235M -16.05B -236M -1.63B -631M -8.24B -638M -624M -26.53B |
Employees
901
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-04 | CN¥5.880 | -1.34% | 21,326,800 |
| 26-09-03 | CN¥5.960 | -1.49% | 25,095,000 |
| 26-09-02 | CN¥6.050 | -1.14% | 28,753,040 |
| 26-09-01 | CN¥6.120 | +2.34% | 40,609,717 |
| 26-08-31 | CN¥5.980 | -4.78% | 54,217,859 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 002038 Stock
Select your edition
All financial news and data tailored to specific country editions
